Network Pharmacology Based Research on the Combination Mechanism Between Escin and Low Dose Glucocorticoids in Anti-rheumatoid Arthritis
Rheumatoid arthritis (RA) is characterized by chronic progressive symmetrical synovitis and destruction of multiple joints. Glucocorticoids (GCs) are widely used in the treatment of RA. However, their adverse effects can be serious. Escin, which is isolated from Aesculus hippocastanum L., has been r...
Main Authors: | Leiming Zhang, Yanan Huang, Chuanhong Wu, Yuan Du, Peng Li, Meiling Wang, Xinlin Wang, Yanfang Wang, Yanfei Hao, Tian Wang, Baofeng Fan, Zhuye Gao, Fenghua Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00280/full |
Similar Items
-
Glucocorticoid-Like Activity of Escin: A New Mechanism for an Old Drug
by: Gallelli L, et al.
Published: (2021-02-01) -
The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
by: Leiming Zhang, et al.
Published: (2021-11-01) -
Evaluation of the modified combined glucocorticoid toxicity index in rheumatoid arthritis: Preliminary data
by: V. V. Lebedeva, et al.
Published: (2020-02-01) -
Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience
by: Wenhui Xie, et al.
Published: (2023-01-01) -
EULAR recommendation for the management of rheumatoid arthritis (2013): glucocorticoid use
by: N.V. Chichasova
Published: (2014-05-01)